1 year return (CAGR)
167.33%
Enliven Therapeutics Inc. Exchange (NASDAQ, USD)
ELVN
53.36
-1.07 (-1.97%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
47.49%
5 year return (CAGR)
-6.02%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
3.91B
Price/Sales
-
Ent value
3.79B
Price/Book
4.37
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-9.23%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 54.32 |
| Daily high | 54.50 |
| Daily low | 52.98 |
| Daily Volume | 867K |
| All-time high | 877.92 |
| 1y analyst estimate | 73.90 |
| Beta | 0.24 |
| EPS (TTM) | -1.60 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ELVN | S&P500 | |
| Current price drop from All-time high | -93.92% | -2.63% |
| Highest price drop | -98.85% | -56.47% |
| Date of highest drop | 12 Dec 2023 | 9 Mar 2009 |
| Avg drop from high | -88.29% | -10.68% |
| Avg time to new high | 82 days | 12 days |
| Max time to new high | 1573 days | 1805 days |
News
